A630018P17Rik Activators
Chemical activators of transcription elongation factor A (SII) N-terminal and central domain containing can initiate a cascade of intracellular events resulting in the protein's phosphorylation and subsequent activation. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioleoyl-sn-glycerol (DAG) both serve as activators of protein kinase C (PKC), which directly phosphorylates transcription elongation factor A (SII) N-terminal and central domain containing. Forskolin, by increasing intracellular cyclic AMP (cAMP) levels, activates protein kinase A (PKA), another kinase that can phosphorylate transcription elongation factor A (SII) N-terminal and central domain containing. Meanwhile, 5-Azacytidine affects DNA methylation patterns, which can indirectly lead to the activation of upstream kinases responsible for phosphorylating the protein.
Epidermal Growth Factor (EGF) and Insulin trigger their respective receptor tyrosine kinases, initiating signaling cascades that converge on kinases capable of targeting transcription elongation factor A (SII) N-terminal and central domain containing. Ionomycin, by raising intracellular calcium levels, can activate calmodulin-dependent kinases, which are also potential enzymes for phosphorylating transcription elongation factor A (SII) N-terminal and central domain containing. Inhibitors of protein phosphatases such as Okadaic acid, Sodium orthovanadate, Calyculin A, and Cantharidin lead to an overall increase in the phosphorylation state of cellular proteins, thereby promoting the phosphorylation of transcription elongation factor A (SII) N-terminal and central domain containing. Anisomycin, by activating stress-activated protein kinase pathways, also contributes to the phosphorylation and activation of transcription elongation factor A (SII) N-terminal and central domain containing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate transcription elongation factor A (SII) N-terminal and central domain containing, leading to its activation for transcription elongation processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine leads to hypomethylation of DNA, which may result in the activation of certain kinases that can phosphorylate and activate transcription elongation factor A (SII) N-terminal and central domain containing. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation can initiate a signaling cascade that may activate kinases capable of phosphorylating transcription elongation factor A (SII) N-terminal and central domain containing, hence enhancing its transcription elongation function. | ||||||
1,2-Dioleoyl-sn-glycerol | 24529-88-2 | sc-204958 sc-204958A | 10 mg 25 mg | $114.00 $170.00 | ||
DAG is a secondary messenger that can activate PKC. Activated PKC might phosphorylate transcription elongation factor A (SII) N-terminal and central domain containing, which is a mechanism for its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinases. These kinases could phosphorylate transcription elongation factor A (SII) N-terminal and central domain containing, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits phosphatases, leading to an increase in the phosphorylation state of proteins. This could result in enhanced phosphorylation and activation of transcription elongation factor A (SII) N-terminal and central domain containing. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
As a phosphatase inhibitor, sodium orthovanadate can increase the phosphorylation state of proteins, potentially including transcription elongation factor A (SII) N-terminal and central domain containing, leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like okadaic acid, inhibits phosphatases which could lead to increased phosphorylation and activation of transcription elongation factor A (SII) N-terminal and central domain containing. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin can act as a stress-activated protein kinase pathway activator. This pathway could phosphorylate and activate transcription elongation factor A (SII) N-terminal and central domain containing. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
By inhibiting protein phosphatases, cantharidin may cause an increase in the phosphorylation and subsequent activation of transcription elongation factor A (SII) N-terminal and central domain containing. | ||||||